A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset DiabetesBen Boursi, Yu‐Xiao Yang, Anil K. Rustgi et al.|Gastroenterology|2016Cited by 193
Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal AdenocarcinomaErin M. Bange, Ronac Mamtani, Abigail Doucette et al.|JCO Oncology Practice|2020Cited by 64
Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancerOfer Margalit, Ben Boursi, Ronac Mamtani et al.|European Journal of Cancer|2018Cited by 48
Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset DiabetesLouise Wang, Yu‐Xiao Yang, Henry A. Glick et al.|Clinical Gastroenterology and Hepatology|2021Cited by 30